Page 1650 - Clinical Small Animal Internal Medicine

1588 Index

atrioventricular block 211–212 azotemia basic life support 366–367
VetBooks.ir epidemiology/signalment 211 acute poisoning 438, 440 Bates bodies 492, 492
acute kidney injury 1092
basophilic leukemia 1228–1229
diagnosis 211, 212
bats
etiology/pathophysiology 211
dialysis 1176–1177
history and clinical signs 211 feline hyperthyroidism 79 Ebola virus 901
treatment and prognosis 212 glomerular disease 1103, 1106 rabies 891–892, 894–896
atrioventricular septal defects hypoadrenocorticism 83, 90 BB see beta‐adrenergic blockers
(AVSD) 233, 243 Bcl‐2 proteins 75–76, 1207
ATT see Animal Trauma Triage b behavioral problems 1571–1579
atypical hypoadrenocorticism BA see bile acids causing a physical illness 1572
87–88 babesiosis 1016–1017 diagnostics/treatment declined
auscultation diagnosis 1017 because of preexisting
cardiovascular disease 122–125, epidemiology 1016 problem 1572
122, 124–125 etiology/pathophysiology 1016 human‐directed aggression 1574
congenital heart disease history and clinical managing client
235–237, 237 signs 1016–1017 expectations 1577–1578
pleural effusion 335 hypoglycemia 108 physical etiologies 1573–1574
respiratory auscultation signalment 1016 preexisting problem hindering
124–125 treatment and prognosis 1017 diagnostics/treatment 1572
respiratory pattern‐based approach bacillary angiomatosis 921, 922 presentations 1571–1572
to dyspnea 291–292 Bacillus anthracis see anthrax psychological etiologies 1574
trauma and burns 448 bacteremia 923, 923, 951 rabies 893
valvular heart disease 247 bacterial infections referrals 1574–1577, 1575, 1576
autoagglutination 1219 approach to the dermatologic safety and avoidance: short‐term
autoimmune and immune‐mediated patient 1393 recommendations 1577
skin disease 1423–1431 bacterial meningoencephalitis 784 secondary to medical treatment
autoimmune subepidermal blistering laboratory diagnosis 844–845 1572
diseases 1427–1428, 1427 principles of therapy of dermatologic secondary to physical illness
canine familial dermatomyositis diseases 1571–1572
1423, 1424 1400–1401 triage for internists and general
cutaneous lupus erythematosus see also individual agents/diseases practitioners 1572–1574, 1573
1424–1427, 1426 bacterial pyodermas see pyoderma beneficence principle 1561–1563
erythema multiforme 1423–1424 BAL see bronchoalveolar lavage benign masses see mass lesions
pemphigus complex 1428–1430, ballooning 561 benign nodular hyperplasia 668
1429 bandages see wound care benign prostatic hyperplasia
toxic epidermal necrolysis 1424 barium‐impregnated polyethylene (BPH) 1157–1160
uveodermatologic spheres (BIPS) 568, 572 diagnosis 1158–1159, 1159, 1160
syndrome 1430–1431 barometric whole‐body etiology 1157
autoimmune polyglandular syndromes plethysmography (BWBP) 299 history and clinical signs 1157
(APS) baroreceptors 404 prognosis 1160
canine 113–116 bartonellosis 919–924 treatment 1159–1160
diagnosis and prognosis 114 diagnosis 922–923, 922–923, 923 benzodiazepines 710, 1187
etiology/pathophysiology epidemiology 919–920 BER see basal energy requirement
113–114 etiology/pathophysiology 919, 920 beta‐adrenergic blockers (BB)
history and clinical signs 114 history and clinical signs canine chronic bronchitis 308
treatment 114–115 920–921, 921–922, 921 canine myocardial disease 260
autologous mesenchymal stem cell hypoglycemia 109 cardiogenic shock 419
therapy 538 prognosis 924 congenital heart disease 240
autonomic nervous system (ANS) 404 public health implications 924 feline bronchial asthma 300
autonomy principle 1561–1563 signalment 920 heart failure 183, 187, 190–191
AV see atrioventricular treatment 923–924 supraventricular arrhythmias
AVSAB see American Veterinary valvular heart disease 250–251 212, 214, 217
Society of Animal Behavior basal cell tumors see trichoblastomas systemic hypertension 222–223
AVSD see atrioventricular septal defects basal energy requirement (BER) ventricular arrhythmias 204
azoles/triazoles 1050–1052 362, 452–453 beta‐lactams 1045